Sagimet Biosciences Inc.(SGMT)

$7.44—

Chart

Sagimet Biosciences Inc.(SGMT)

NASDAQ

$7.44—

Chart Studio

SGMT(SGMT)

SGMT

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.28

Aug 12, 2026 · Reports before open

FY2030E EPS$0.37

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

6 Buy (86%)1 Hold (14%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

686%

Hold

114%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$8.00

+7.5%

Consensus

$8.00

+7.5%

Bull

$8.00

+7.5%

12-Month Target Range7 analysts

$8.00$8.00$8.00

Current $7.44Consensus

Current Price

$7.44

Upside to Consensus

$0.56

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+6673.86%

EPS—

FY2028

Rev+217.14%

EPS—

FY2029

Rev+283.11%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$111,111	$8M	$24M	$91M	$252M
Low	$111,111	$8M	$24M	$91M	$252M
High	$111,111	$8M	$24M	$91M	$252M
EBITDA Avg	$66,666	$5M	$14M	$55M	$151M
Low	$66,666	$5M	$14M	$55M	$151M
High	$66,666	$5M	$14M	$55M	$151M
EBIT Avg	$66,666	$5M	$14M	$55M	$151M
Low	$66,666	$5M	$14M	$55M	$151M
High	$66,666	$5M	$14M	$55M	$151M
Net Income Avg	$-40M	$-39M	$-64M	$-32M	$12M
Low	$-50M	$-54M	$-98M	$-32M	$12M
High	$-30M	$-25M	$-29M	$-32M	$12M
EPS Avg	$-1.20	$-1.25	$-1.63	$-0.98	$0.37
Low	$-1.54	$-1.66	$-3.03	$-0.98	$0.37
High	$-0.93	$-0.77	$-0.90	$-0.98	$0.37
Analysts (Rev / EPS)	6 / 7	6 / 7	8 / 8	7 / 6	7 / 6

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$166,667	$166,667	$500,000	$500,000	$500,000	$500,000
Low	$166,667	$166,667	$500,000	$500,000	$500,000	$500,000
High	$166,667	$166,667	$500,000	$500,000	$500,000	$500,000
EBITDA Avg	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
Low	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
High	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
EBIT Avg	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
Low	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
High	$100,000	$100,000	$300,000	$300,000	$300,000	$300,000
Net Income Avg	$-8M	$-11M	$-7M	$-8M	$-8M	$-7M
Low	$-9M	$-11M	$-7M	$-8M	$-8M	$-7M
High	$-6M	$-11M	$-7M	$-8M	$-8M	$-7M
EPS Avg	$-0.25	$-0.32	$-0.21	$-0.23	$-0.26	$-0.20
Low	$-0.29	$-0.32	$-0.21	$-0.23	$-0.26	$-0.20
High	$-0.20	$-0.32	$-0.21	$-0.23	$-0.26	$-0.20
Analysts (Rev / EPS)	4 / 6	7 / 4	4 / 2	6 / 2	4 / 2	7 / 2

Earnings Surprises

Recent Analyst Actions

Jan 27, 2026Barclays

Sagimet Biosciences initiated with an Equal Weight at Barclays

Target:$8.00

+31.4%from $6.09

Jun 28, 2024Goldman Sachs

Sagimet Biosciences downgraded to Neutral from Buy at Goldman Sachs

Target:$6.00

+46.0%from $4.11

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance